|
[1]
|
Wang, M., Jia, J., Yang, C. and Hu, Q. (2019) Pathogenesis, Disease Course, and Prognosis of Adult-Onset Still’s Disease: An Update and Review. Chinese Medical Journal, 132, 2856-2864. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Yamaguchi, M., Ohta, A., Tsunematsu, T., et al. (1992) Preliminary Criteria for Classification of Adult Still’s Disease. The Journal of Rheumatology, 19, 424-430.
|
|
[3]
|
Li, X., Dong, C., Ma, X. and Wang, Y. (2021) 18F-FDG PET/CT Associates with Disease Activity and Clinical Recurrence of AOSD Patients. Frontiers in Medicine, 8, Article ID: 668323. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
Feist, E., Mitrovic, S. and Fautrel, B. (2018) Mechanisms, Biomarkers and Targets for Adult-Onset Still’s Disease. Nature Reviews Rheumatology, 14, 603-618. [Google Scholar] [CrossRef] [PubMed]
|
|
[5]
|
Wang, R., Li, T., Ye, S., Tan, W., Zhao, C., Li, Y., et al. (2020) Macrophage Activation Syndrome Associated with Adult-Onset Still’s Disease: A Multicenter Retrospective Analysis. Clinical Rheumatology, 39, 2379-2386. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Henter, J., Horne, A., Aricó, M., Egeler, R.M., Filipovich, A.H., Imashuku, S., et al. (2006) HLH‐2004: Diagnostic and Therapeutic Guidelines for Hemophagocytic Lymphohistiocytosis. Pediatric Blood & Cancer, 48, 124-131. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Pouchot, J., Sampalis, J.S., Beaudet, F., Carette, S., Décary, F., Salusinsky-Sternbach, M., et al. (1991) Adult Stillʼs Disease. Medicine, 70, 118-136. [Google Scholar] [CrossRef]
|
|
[8]
|
Khare, N., Jinkala, S.R. and Kanungo, S. (2020) Performance of Hscore in Reactive Hemophagocytic Lymphohistiocytosis. Indian Journal of Hematology and Blood Transfusion, 37, 256-263. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
Funauchi, M., Ikoma, S., Kishimoto, K., Shimazu, H., Nozaki, Y., Sugiyama, M., et al. (2008) A Case of Adult Onset Still’s Disease Showing Marked Accumulation in the Liver and Spleen, on Positron Emission Tomography-CT Images. Rheumatology International, 28, 1061-1064. [Google Scholar] [CrossRef] [PubMed]
|
|
[10]
|
Wang, J., Wang, D., Zhang, Q., Duan, L., Tian, T., Zhang, X., et al. (2015) The Significance of Pre-Therapeutic F-18-FDG PET-CT in Lymphoma-Associated Hemophagocytic Lymphohistiocytosis When Pathological Evidence Is Unavailable. Journal of Cancer Research and Clinical Oncology, 142, 859-871. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Nielsen, B.D., Gormsen, L.C., Hansen, I.T., Keller, K.K., Therkildsen, P. and Hauge, E. (2018) Three Days of High-Dose Glucocorticoid Treatment Attenuates Large-Vessel 18F-FDG Uptake in Large-Vessel Giant Cell Arteritis but with a Limited Impact on Diagnostic Accuracy. European Journal of Nuclear Medicine and Molecular Imaging, 45, 1119-1128. [Google Scholar] [CrossRef] [PubMed]
|